Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Miltenyi Biomedicine Gmbh

Clinical trials sponsored by Miltenyi Biomedicine Gmbh, explained in plain language.

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New 'Living Drug' trial offers hope for Tough-to-Treat lymphoma

Disease control Ongoing

This study is testing a new type of personalized cell therapy called MB-CART2019.1 for adults with an aggressive form of lymphoma that has come back or not responded to standard chemotherapy. The therapy involves modifying a patient's own immune cells to better find and attack ca…

Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC
New 'Living Drug' tested as last hope for tough blood cancers

Disease control Ongoing

This is an early-stage safety study testing a new type of personalized cell therapy called MB-CART19.1. It aims to find a safe dose for adults and children whose B-cell blood cancers (like leukemia or lymphoma) have returned or not responded to standard treatments. The therapy in…

Phase: PHASE1 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC